Regulation of TNF receptors.
Tsujimoto
M
M
Suntory Institute for Biomedical Research, Mishima, Osaka, Japan.
Oku
N
N
D003907:Dexamethasone / Q000494:pharmacology; D015536:Down-Regulation / Q000187:drug effects; D005786:Gene Expression Regulation / Q000187:drug effects*; D006801:Humans; D007372:Interferons / Q000494:pharmacology; D007375:Interleukin-1 / Q000494:pharmacology; D007376:Interleukin-2 / Q000494:pharmacology; D037102:Lectins; D008070:Lipopolysaccharides; D009856:Oncogene Proteins, Viral / Q000502:physiology; D018719:Erb-b2 Receptor Tyrosine Kinases; D011956:Receptors, Cell Surface / Q000096:biosynthesis*; D018124:Receptors, Tumor Necrosis Factor; D013755:Tetradecanoylphorbol Acetate / Q000494:pharmacology; D013972:Thyrotropin / Q000494:pharmacology; D014409:Tumor Necrosis Factor-alpha / Q000494:pharmacology; D015854:Up-Regulation / Q000187:drug effects
D003907:Dexamethasone; D007372:Interferons; D007375:Interleukin-1; D007376:Interleukin-2; D037102:Lectins; D008070:Lipopolysaccharides; D009856:Oncogene Proteins, Viral; D018719:Erb-b2 Receptor Tyrosine Kinases; D011956:Receptors, Cell Surface; D018124:Receptors, Tumor Necrosis Factor; D013755:Tetradecanoylphorbol Acetate; D013972:Thyrotropin; D014409:Tumor Necrosis Factor-alpha